FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220998575> ?p ?o ?g. }

• W4220998575 endingPage "1412" @default.
• W4220998575 startingPage "1412" @default.
• W4220998575 abstract "This study aims to evaluate the real-world effectiveness of regdanvimab on clinical outcomes in patients with mild to moderate coronavirus disease 2019 (COVID-19).This retrospective observational study included 152 patients (89 received regdanvimab and 63 did not) diagnosed with mild to moderate COVID-19 between August 2021 and October 2021 and admitted to Armed Forces Goyang Hospital. We collected information on the use of regdanvimab, remdesivir, dexamethasone, and supplemental oxygen; symptom severity score (SSS); and laboratory test results. A linear mixed-effects model was used to test the effectiveness of regdanvimab usage on SSS and the results of laboratory tests. A multivariate logistic regression model was used to calculate the odds ratio (OR) for additional therapeutic options, such as remdesivir, dexamethasone, and supplemental oxygen.The patients who received regdanvimab were older, showed a higher rate of vaccination, and had a higher Charlson comorbidity index, initial body temperature, and percentages of pneumonia at admission. The use of regdanvimab showed no interactive effects on the SSS and laboratory findings. Older age, male sex, obesity, high initial body temperature, and the presence of pneumonia at admission were associated with increased ORs for the use of these additional treatments. The use of regdanvimab reduced the probability of requiring additional therapies such as remdesivir, dexamethasone, and oxygen supplementation by 90.3% (95% confidence interval (CI), 60.3-97.6), 85.8% (95% CI, 34.2-96.9), and 89.8% (95% CI, 48.3-98), respectively.Regdanvimab usage was well tolerated and was associated with a decreased probability of requiring remdesivir, dexamethasone, and oxygen therapy. However, changes in SSS were not significantly different by the drug usage." @default.
• W4220998575 created "2022-04-03" @default.
• W4220998575 creator A5030906483 @default.
• W4220998575 creator A5034936407 @default.
• W4220998575 creator A5062866087 @default.
• W4220998575 creator A5065749375 @default.
• W4220998575 creator A5065981202 @default.
• W4220998575 creator A5066549957 @default.
• W4220998575 date "2022-03-04" @default.
• W4220998575 modified "2023-10-14" @default.
• W4220998575 title "Real-World Efficacy of Regdanvimab on Clinical Outcomes in Patients with Mild to Moderate COVID-19" @default.
• W4220998575 cites W3009912996 @default.
• W4220998575 cites W3022455098 @default.
• W4220998575 cites W3025190337 @default.
• W4220998575 cites W3027630905 @default.
• W4220998575 cites W3033721794 @default.
• W4220998575 cites W3044660350 @default.
• W4220998575 cites W3047144258 @default.
• W4220998575 cites W3048257074 @default.
• W4220998575 cites W3090218328 @default.
• W4220998575 cites W3096658347 @default.
• W4220998575 cites W3111431752 @default.
• W4220998575 cites W3113200620 @default.
• W4220998575 cites W3119881634 @default.
• W4220998575 cites W3157733336 @default.
• W4220998575 cites W3175095247 @default.
• W4220998575 cites W3195688501 @default.
• W4220998575 cites W3200744691 @default.
• W4220998575 cites W4210311296 @default.
• W4220998575 cites W4210642183 @default.
• W4220998575 cites W4212988737 @default.
• W4220998575 cites W4226004814 @default.
• W4220998575 doi "https://doi.org/10.3390/jcm11051412" @default.
• W4220998575 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35268503" @default.
• W4220998575 hasPublicationYear "2022" @default.
• W4220998575 type Work @default.
• W4220998575 citedByCount "6" @default.
• W4220998575 countsByYear W42209985752022 @default.
• W4220998575 countsByYear W42209985752023 @default.
• W4220998575 crossrefType "journal-article" @default.
• W4220998575 hasAuthorship W4220998575A5030906483 @default.
• W4220998575 hasAuthorship W4220998575A5034936407 @default.
• W4220998575 hasAuthorship W4220998575A5062866087 @default.
• W4220998575 hasAuthorship W4220998575A5065749375 @default.
• W4220998575 hasAuthorship W4220998575A5065981202 @default.
• W4220998575 hasAuthorship W4220998575A5066549957 @default.
• W4220998575 hasBestOaLocation W42209985751 @default.
• W4220998575 hasConcept C126322002 @default.
• W4220998575 hasConcept C148699463 @default.
• W4220998575 hasConcept C151956035 @default.
• W4220998575 hasConcept C156957248 @default.
• W4220998575 hasConcept C167135981 @default.
• W4220998575 hasConcept C23131810 @default.
• W4220998575 hasConcept C2777914695 @default.
• W4220998575 hasConcept C2779134260 @default.
• W4220998575 hasConcept C2779159551 @default.
• W4220998575 hasConcept C2780401358 @default.
• W4220998575 hasConcept C2780630273 @default.
• W4220998575 hasConcept C3008058167 @default.
• W4220998575 hasConcept C38180746 @default.
• W4220998575 hasConcept C44249647 @default.
• W4220998575 hasConcept C524204448 @default.
• W4220998575 hasConcept C71924100 @default.
• W4220998575 hasConceptScore W4220998575C126322002 @default.
• W4220998575 hasConceptScore W4220998575C148699463 @default.
• W4220998575 hasConceptScore W4220998575C151956035 @default.
• W4220998575 hasConceptScore W4220998575C156957248 @default.
• W4220998575 hasConceptScore W4220998575C167135981 @default.
• W4220998575 hasConceptScore W4220998575C23131810 @default.
• W4220998575 hasConceptScore W4220998575C2777914695 @default.
• W4220998575 hasConceptScore W4220998575C2779134260 @default.
• W4220998575 hasConceptScore W4220998575C2779159551 @default.
• W4220998575 hasConceptScore W4220998575C2780401358 @default.
• W4220998575 hasConceptScore W4220998575C2780630273 @default.
• W4220998575 hasConceptScore W4220998575C3008058167 @default.
• W4220998575 hasConceptScore W4220998575C38180746 @default.
• W4220998575 hasConceptScore W4220998575C44249647 @default.
• W4220998575 hasConceptScore W4220998575C524204448 @default.
• W4220998575 hasConceptScore W4220998575C71924100 @default.
• W4220998575 hasFunder F4320322120 @default.
• W4220998575 hasIssue "5" @default.
• W4220998575 hasLocation W42209985751 @default.
• W4220998575 hasLocation W42209985752 @default.
• W4220998575 hasLocation W42209985753 @default.
• W4220998575 hasOpenAccess W4220998575 @default.
• W4220998575 hasPrimaryLocation W42209985751 @default.
• W4220998575 hasRelatedWork W1992661224 @default.
• W4220998575 hasRelatedWork W2037611947 @default.
• W4220998575 hasRelatedWork W2098931901 @default.
• W4220998575 hasRelatedWork W2138334887 @default.
• W4220998575 hasRelatedWork W2218945907 @default.
• W4220998575 hasRelatedWork W2335988042 @default.
• W4220998575 hasRelatedWork W2971695752 @default.
• W4220998575 hasRelatedWork W3010075638 @default.
• W4220998575 hasRelatedWork W3213017456 @default.
• W4220998575 hasRelatedWork W4322739880 @default.
• W4220998575 hasVolume "11" @default.
• W4220998575 isParatext "false" @default.

• next